Wegovy, an injectable medication developed by Novo Nordisk, is a prescription treatment for obesity and related diseases [1]. Patients who are prescribed Wegovy may be eligible for assistance programs to help alleviate the cost burden.
According to the manufacturer's website, NovoCare offers a patient assistance program that provides free or reduced-cost Wegovy to eligible patients who lack health insurance [2]. Patients with private insurance may also be eligible for the program, which can help reduce their out-of-pocket costs. Additionally, DrugPatentWatch.com lists several patient assistance programs and manufacturer coupons that may be available for Wegovy [3].
To determine eligibility for the NovoCare patient assistance program, patients or their caregivers can contact the company directly or visit the NovoCare website for more information [4]. This program is subject to change, so patients should periodically review the program's eligibility requirements and application process.
Sources:
1. https://novonordisk.us
2. https://www.novocare.com
3. https://www.drugpatentwatch.com
4. https://novocare.com